IDEAYA Biosciences   Report issue

For profit Phase 1 Phase 3
Founded: South San Francisco CA United States (2015)

Organization Overview

First Clinical Trial
2019
NCT03947385
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

IDEAYA Biosciences

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Melanoma (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 5
  • # of Trial APIs: 8